Edition:
United States

St. Jude Medical Inc (STJ)

STJ on New York Consolidated

79.64USD
23 Sep 2016
Change (% chg)

$0.03 (+0.04%)
Prev Close
$79.61
Open
$79.65
Day's High
$79.88
Day's Low
$79.40
Volume
1,174,683
Avg. Vol
3,088,952
52-wk High
$84.00
52-wk Low
$48.83

Latest Key Developments (Source: Significant Developments)

St. Jude Medical says filed lawsuit against Muddy Waters, Medsec
Wednesday, 7 Sep 2016 07:43am EDT 

St. Jude Medical Inc : St. Jude Medical Inc says it has filed lawsuit against Muddy Waters Consulting, Muddy Waters Capital, Medsec Holdings, Medsec LLC . Lawsuit relates statements regarding St. Jude Medical's implantable cardiac management devices . Lawsuit filed on Wednesday alleges that defendants intentionally disseminated "false and misleading information" .Lawsuit was filed in United States District Court for District of Minnesota.  Full Article

St Jude and Abbott Labs receive request for additional information from U.S. FTC
Tuesday, 12 Jul 2016 06:31pm EDT 

St Jude Medical: Abbott labs, st. Jude medical each received request for additional information from u.s. Ftc relating to abbott's potential acquisition of st. Jude medical .Effect of requests, which were issued under hart-scott rodino antitrust improvements act, is to extend waiting period imposed by Hart-Scott-Rodino act.  Full Article

St. Jude Medical receives FDA approval of SyncAV CRT software
Monday, 11 Jul 2016 08:00am EDT 

St. Jude Medical Inc :FDA approval and launch of SyncAV CRT software, designed to build upon company's first-to-market multipoint pacing technology.  Full Article

St. Jude Medical says announces CE Mark approval and launch of SyncAV CRT software
Thursday, 23 Jun 2016 08:00am EDT 

St. Jude Medical Inc :Announced ce mark approval and launch of syncav((tm))crt software.  Full Article

St Jude Medical announces European launch of latest in pressurewire guidewire technology
Wednesday, 18 May 2016 08:00am EDT 

St. Jude Medical Inc : Announces European launch of latest in PressureWire Guidewire technology to measure pressure differences across narrowed coronary arteries .Pressurewire X Guidewire European launch will include a measured rollout to targeted countries throughout 2016.  Full Article

St. Jude Medical Inc says announces U.S. launch of Trifecta surgical valve
Monday, 16 May 2016 08:00am EDT 

St. Jude Medical Inc - :Announces U.S. launch of Trifecta surgical valve.  Full Article

St. Jude Medical, Inc declare second quarter dividend of $0.31 per share
Wednesday, 4 May 2016 09:15am EDT 

St. Jude Medical, Inc:Board of directors declared a second quarter dividend of $0.31 per common share.Dividend is payable on July 29, 2016, to shareholders of record date as on June 30, 2016.  Full Article

Abbott Laboratories to acquire St. Jude medical
Thursday, 28 Apr 2016 06:48am EDT 

Abbott Laboratories:To acquire st. Jude medical.Transaction expected to be accretive to abbott's adjusted earnings per share in first full year after closing and increasing thereafter.Abbott laboratories says st. Jude medical shareholders will receive $46.75 in cash and 0.8708 shares of abbott common stock.Total transaction equity value of $25 billion.Says Abbott intends to fund cash portion of this transaction with medium-and long-term debt.Transaction has been approved by boards of directors of st. Jude medical and abbott.Says st. Jude medical's net debt of approximately $5.7 billion will be assumed or refinanced by abbott.Expects to issue $3 billion of common stock in secondary market to rebalance its capital structure.Combination is anticipated to result in annual pre-tax synergies of $500 million by 2020.Combination is anticipated to result in annual pre-tax synergies of $500 million by 2020.st. Jude medical's net debt of approximately $5.7 billion will be assumed or refinanced by abbott.Says st. Jude medical's net debt of approximately $5.7 billion will be assumed or refinanced by abbott.Evercore is serving as lead financial advisor for abbott with wachtell, lipton, rosen & katz serving as legal counsel.Evercore is serving as lead financial advisor for abbott.Guggenheim securities is acting as financial advisor and gibson, dunn & crutcher llp is serving as legal counsel to st. Jude medical.  Full Article

St. Jude Medical Inc gives Q2 2016 guidance; reaffirms FY 2016 revenue guidance; increases FY 2016 EPS guidance
Wednesday, 20 Apr 2016 02:15am EDT 

St. Jude Medical Inc:Expects Q2 2016 revenue to grow in the range of 1 percent to 3 percent on a comparable constant currency basis compared to Q2 2015 with currency negatively impacting second quarter revenue by about $10 million to $15 million.Expects consolidated adjusted net earnings for Q2 2016 to be in the range of $1.05 to $1.07 per share.Says for FY 2016, the company continues to expect total revenue to grow in the range of 2 percent to 4 percent on a comparable constant currency basis with currency negatively impacting FY 2016 revenue by about $35 million to $55 million.Increases FY 2016 consolidated adjusted net earnings by $0.06 to be in the range of $4.01 to $4.11 per share.  Full Article

St. Jude Medical, Inc announces increase in quarterly dividend
Friday, 19 Feb 2016 01:17pm EST 

St. Jude Medical, Inc:Declares 7 pct increase in the company's quarterly dividend to $0.31 per common share.Payable April 29, 2016, to shareholders of record on March 31, 2016.  Full Article

Photo

St. Jude's lawsuit against short-seller faces steep climb: lawyers

St. Jude Medical will face an uphill battle in its corporate defamation lawsuit over a short-seller's report that said the medical device company's heart implants were vulnerable to cyber attacks, lawyers familiar with such cases said.